Peptides Recognized By Melanoma-specific Cytoxic Lyphocytes, And Uses Therefor
European Patent
95911773.0
Filed on 1995-02-16
95911773.0
Filed on 1995-02-16
Peptides Recognized By Melanoma-specific Cytoxic Lyphocytes, And Uses Therefor
Canada
2182889
Filed on 1995-02-16
2182889
Filed on 1995-02-16
Peptides Recognized By Melanoma-specific Cytoxic Lyphocytes, And Uses Therefor
Australia
19215/95
Filed on 1995-02-16
19215/95
Filed on 1995-02-16
Peptides Recognized By Melanoma-specific Cytoxic Lyphocytes, And Uses Therefor
Patent Cooperation Treaty
PCT/US1995/001991
Filed on 1995-02-16
PCT/US1995/001991
Filed on 1995-02-16
Peptides Recognized By Melanoma-specific Cytoxic Lyphocytes, And Uses Therefor
US Application 09/209,180
Filed on 1998-12-10
Filed on 1998-12-10
Peptides Recognized By Melanoma-specific Cytoxic Lyphocytes, And Uses Therefor
US Patent 6,660,276
Filed on 1994-04-29
Filed on 1994-04-29
Peptides Recognized By Melanoma-specific Cytoxic Lyphocytes, And Uses Therefor
US Application 08/197,399
Filed on 1994-02-16
Filed on 1994-02-16
Chemoprotectant Compositions
Patent Cooperation Treaty
PCT/US2002/035437
Filed on 2002-11-05
PCT/US2002/035437
Filed on 2002-11-05
Radioprotective Agents
Patent Cooperation Treaty
PCT/US2001/018772
Filed on 2001-06-12
PCT/US2001/018772
Filed on 2001-06-12
Replication-Competent Adenoviral Vectors
US Patent 8,926,987
Filed on 2005-11-17
Filed on 2005-11-17